Form 4 Ligand Pharmaceuticals Incorporated For: 15 June

Ligand Pharmaceuticals Incorporated has filed a Form 4 with the Securities and Exchange Commission, dated June 15. This filing typically reports the acquisition or disposition of the company's securities by its officers, directors, or beneficial owners. The details of the transactions and the individuals involved are outlined in the submitted document, which is part of the regulatory requirements for publicly traded companies.

Read More